Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Upgrade
Genesco upgraded to Buy from Neutral at CL King » 08:56
01/21/20
01/21
08:56
01/21/20
08:56
GCO

Genesco

$43.17 /

-0.415 (-0.95%)

CL King analyst Steven…

CL King analyst Steven Marotta upgraded Genesco to Buy from Neutral with a $53 price target. Genesco pre-announced slightly better than expected sales results and guided above the midpoint of the previous non-GAAP EPS guidance range, noted Marotta, who sees the risk of another "seismic shift in fashion, such as occurred in early 2016, as exceedingly low."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
Earnings
Genesco sees FY20 adj. EPS above midpoint of $4.10-$4.40 range, consensus $4.30 » 07:00
01/13/20
01/13
07:00
01/13/20
07:00
GCO

Genesco

$47.82 /

+0.05 (+0.10%)

Robert Dennis, Chairman,…

Robert Dennis, Chairman, President and CEO of Genesco, said, "Overall, we enjoyed a solid Holiday selling season, with sales results at the higher end of our expectations. Journeys once again led the way, and we were pleased that Schuh delivered better than expected results. January is off to a good start as we look to deliver our 11th consecutive quarter of positive comparable sales for our footwear businesses. Although, the start of the month was strong, we expect that to moderate through the course of the month. We now expect that adjusted earnings per share will be above the midpoint of our guidance range."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Genesco reports comparable sales for quarter-to-date period ended Jan. 9 up 2% » 06:56
01/13/20
01/13
06:56
01/13/20
06:56
GCO

Genesco

$47.82 /

+0.05 (+0.10%)

Genesco announced that…

Genesco announced that comparable sales, including both stores and direct sales, increased 2% for the quarter-to-date period ended January 9. Same store sales decreased 1% and sales for the company's e-commerce businesses increased 21% on a comparable basis for that period.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Genesco closes Togast acquisition, sees accretion in FY21 earnings » 17:05
01/02/20
01/02
17:05
01/02/20
17:05
GCO

Genesco

$47.51 /

-0.41 (-0.86%)

, LEVI

Levi Strauss

$19.10 /

-0.175 (-0.91%)

Genesco (GCO) announced…

Genesco (GCO) announced that it has closed the acquisition of the U.S. assets of New York-based Togast, previously announced on December 18. Togast is a company that specializes in the design, sourcing and sale of licensed footwear. The acquisition is expected to be accretive to Genesco's fiscal 2021 earnings. As planned, at closing, Genesco also entered into a new U.S. footwear license agreement for men, women and children for Levi's (LEVI), as well as renewed and extended its men's Dockers footwear license. The Togast purchase expands Genesco's portfolio to include footwear licenses for G.H. Bass & Co., ADIO and FUBU, among others.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
Hot Stocks
Genesco to buy footwear licensee Togast enters into Levi's footwear license pact » 17:21
12/18/19
12/18
17:21
12/18/19
17:21
GCO

Genesco

$50.53 /

+1.01 (+2.04%)

, LEVI

Levi Strauss

$19.86 /

+0.58 (+3.01%)

Genesco (GCO) announced…

Genesco (GCO) announced it has entered into a definitive asset purchase agreement to acquire New York-based Togast, which specializes in the design, sourcing and sale of licensed footwear. The purchase price for the acquisition is $33.7M in cash at closing, plus up to an additional $34M in cash contingent on the achievement of financial targets over the next four years. The purchase price paid at closing is expected to be funded from cash on hand. The transaction, which is subject to customary closing conditions, is expected to be completed in January 2020, and is expected to be accretive to next year's earnings. Prior to the acquisition, Togast served as distributor for Levi's footwear in the United States. Commensurate with the closing of this transaction, Genesco will enter into a new U.S. footwear license agreement for men, women and children for Levi's(R), as well as renew and extend its men's Dockers(R) footwear license. The addition of privately owned Togast brings to Genesco new sources of revenue and synergistic product development and offshore sourcing capabilities, which complement and enhance Genesco's Licensed Brands division. In addition, the Togast purchase expands Genesco's portfolio to include footwear licenses for G.H. Bass & Co., ADIO and FUBU, among others. Genesco Chairman, President and Chief Executive Officer Robert J. Dennis said, "The acquisition of Togast adds scale to our successful licensed brands platform. The combination of our licensed business with Togast's strengths furthers our footwear focused strategy by creating an even more robust platform within Genesco that can serve multiple tiers of distribution. We are also excited to add the Levi's(R) footwear license to our portfolio and expand upon our long-standing business relationship with Levi Strauss (LEVI) , which dates back to 1991." Genesco Licensed Brands President Andy Gilbert said, "We are pleased to broaden our portfolio of licensed footwear brands. We immediately recognized the sourcing capabilities and corresponding synergies with Licensed Brands that we would achieve through the acquisition of Togast, and I am personally excited to welcome Tony LoConte and his team to the Genesco family."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Genesco price target raised to $57 from $51 at Pivotal Research » 04:52
12/09/19
12/09
04:52
12/09/19
04:52
GCO

Genesco

$48.81 /

+11.87 (+32.13%)

Pivotal Research analyst…

Pivotal Research analyst Mitch Kummetz raised his price target for Genesco to $57 from $51 saying the company reported a "solid" earnings and same-store-sales beat in Q3. The company also reiterated its fiscal 2020 same-store-sales guidance and raised its earnings outlook by a substantial amount, Kummetz tells investors in a research note. He believes better weather this year could drive some upside at Journeys in Q4 and that Genesco is being overly conservative with its same-store-sales guidance for Schuh. The analyst reiterates a Buy rating on the shares.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Genesco rises 34.1% » 12:00
12/06/19
12/06
12:00
12/06/19
12:00
GCO

Genesco

$49.57 /

+12.63 (+34.19%)

Genesco is up 34.1%, or…

Genesco is up 34.1%, or $12.60 to $49.51.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Genesco rises 19.8% » 10:00
12/06/19
12/06
10:00
12/06/19
10:00
GCO

Genesco

$44.32 /

+7.38 (+19.98%)

Genesco is up 19.8%, or…

Genesco is up 19.8%, or $7.32 to $44.23.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Genesco rises 14.8% » 09:47
12/06/19
12/06
09:47
12/06/19
09:47
GCO

Genesco

$42.38 /

+5.44 (+14.73%)

Genesco is up 14.8%, or…

Genesco is up 14.8%, or $5.47 to $42.38.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fly Intel: Pre-market Movers » 09:09
12/06/19
12/06
09:09
12/06/19
09:09
ALXN

Alexion

$107.42 /

-8.07 (-6.99%)

, UBER

Uber

$28.65 /

-0.405 (-1.39%)

, TTD

Trade Desk

$240.27 /

-3.86 (-1.58%)

, BIG

Big Lots

$19.17 /

-0.75 (-3.77%)

, GCO

Genesco

$36.94 /

+0.38 (+1.04%)

, ULTA

Ulta Beauty

$236.09 /

-3.27 (-1.37%)

, DOCU

DocuSign

$69.51 /

-0.465 (-0.66%)

, DOMO

Domo

$19.47 /

-0.19 (-0.97%)

, ZM

Zoom Video

$69.73 /

-0.22 (-0.31%)

, PD

PagerDuty

$24.99 /

-0.66 (-2.57%)

, YEXT

Yext

$16.62 /

+0.065 (+0.39%)

, CIEN

Ciena

$36.30 /

-0.3 (-0.82%)

HIGHER: Alexion…

HIGHER: Alexion Pharmaceuticals (ALXN), up 6% after the company earlier disclosed that it had "recently engaged in good faith with Elliott Advisors Limited, an affiliate of Elliott Management." The activist investing firm recommended that the drugmaker "immediately launch a proactive sale process," but Alexion said its board of directors had "unanimously decided that conducting a proactive sale process would not be in the best interest of shareholders and the patients we serve at this time"... Trade Desk (TTD), up 6% after Needham analyst Laura Martin upgraded the stock to Buy from Hold with a $325 price target. UP AFTER EARNINGS: Big Lots (BIG), up 6%... Genesco (GCO), up 15%... Ulta Beauty (ULTA), up 8%... DocuSign (DOCU), up 8%... Domo (DOMO), up 2%. DOWN AFTER EARNINGS: Zoom Video (ZM), down 7%... PagerDuty (PD), down 17%...Yext (YEXT), down 22%. ALSO LOWER: Ciena (CIEN), down 4% after UBS analyst Tejas Venkatesh downgraded shares to Sell from Neutral with a price target of $31, down from $43... Uber (UBER), down 1% after releasing its safety report that shares details on Uber's safety progress, processes and data related to reports of the "most critical safety incidents" on its platform. As part of the report, Uber said that fatal physical assault was reported to occur in about 1 in every 122M U.S. trips.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.